Interleukin-6 bares a dark side in sudden unexpected death in epilepsy

Epilepsy and Behavior

Volumn 24, Issue 2, 2012, Pages 285-286

  Nejm, Mariana B ^a   Haidar, André A ^a   Hirata, Aparecida E ^a   Arida, Ricardo M ^a   Naffah Mazacoratti, Maria da Graça ^a   Cavalheiro, Esper A ^a   Cysneiros, Roberta M ^b   Scorza, Fulvio A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

AUTONOMIC NERVOUS SYSTEM; CORRELATIONAL STUDY; EPILEPSY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFLAMMATION; LETTER; MEDICAL RESEARCH; MORTALITY; NONHUMAN; PROTEIN EXPRESSION; SUDDEN DEATH; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CAUSE OF DEATH; DEATH, SUDDEN; EPILEPSY; HEART FAILURE; INFLAMMATION; INTERLEUKIN-6; MYOCARDIUM; RATS; RISK FACTORS;

EID: 84861347896     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.04.113     Document Type: Letter

References (26)

1. Nashef L., Ryvlin P. Sudden unexpected death in epilepsy (SUDEP): update and reflections. Neurol Clin 2009, 27:1063-1074.
2. Duncan J.S., Sander J.W., Sisodiya S.M., Walker M.C. Adult epilepsy. Lancet 2006, 367:1087-1100.
3. Nei M., Hays R. Sudden unexpected death in epilepsy. Curr Neurol Neurosci Rep 2010, 10:319-326.
4. Surges R., Thijs R.D., Tan H.L., Sander J.W. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol 2009, 5:492-504.
5. Stollberger C., Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 2004, 59:51-60.
6. Surges R., Taggart P., Sander J.W., Walker M.C. Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death. Epilepsia 2010, 51:738-744.
7. Nei M., Ho R.T., Abou-Khalil B.W., et al. EEG and ECG in sudden unexplained death in epilepsy. Epilepsia 2004, 45:338-345.
8. Patel P., Dokainish H., Tsai P., Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol 2010, 21:1064-1070.
9. Bozkurt B., Mann D.L., Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev 2010, 15:331-341.
10. Tomson T., Nashef L., Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 2008, 7:1021-1031.
11. Li G., Bauer S., Nowak M., et al. Cytokines and epilepsy. Seizure 2011, 20:249-256.
12. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 1996, 27:1201-1206.
13. Dibbs Z., Thornby J., White B.G., Mann D.L. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 1999, 33:1935-1942.
14. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001, 103:2055-2059.
15. Psychari S.N., Apostolou T.S., Sinos L., Hamodraka E., Liakos G., Kremastinos D.T. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005, 95:764-767.
16. Shorvon S., Tomson T. Sudden unexpected death in epilepsy. Lancet 2011, 10(378):2028-2038.
17. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol (in press) doi:10.1016/j.expneurol.2011.09.033.
18. Vezzani A., Moneta D., Richichi C., et al. Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis. Epilepsia 2002, 43:30-35.
19. Rosell D.R., Nacher J., Akama K.T., McEwen B.S. Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation. Neuroscience 2003, 122:329-348.
20. Moertl D., Hammer A., Steiner S., Hutuleac R., Vonbank K., Berger R. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study. Am Heart J 2011, 161(915):e1-e9.
21. Ferrari R., Bachetti T., Confortini R., et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995, 92:1479-1486.
22. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002, 91:988-998.
23. Schachter S.C. Complementary and alternative medical therapies. Curr Opin Neurol 2008, 21:184-189.
24. DeGiorgio C.M., Miller P. n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy. Epilepsy Behav 2008, 13:712-713.
25. Scorza F.A., Cysneiros R.M., Arida R.M., Terra-Bustamante V.C., de Albuquerque M., Cavalheiro E.A. The other side of the coin: beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav 2008, 13:279-283.
26. Yuen A.W., Sander J.W., Fluegel D., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 2005, 7:253-258.